Researchers from University College London attached a light-sensitive antimicrobial drug to a protein fragment, or peptide, which latches on to a molecule on the surface of the bacteria. The MRSA bugs are targeted while human cells are left alone. The antimicrobial agent releases destructive molecules that kill the bacteria when exposed to the right light wave. Linda Dekker from UCL presented the findings at a meeting of the Society for General Microbiology.